Ray 将来の成長

Future 基準チェック /56

Ray利益と収益がそれぞれ年間66.8%と24%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に18.3% 66.4%なると予測されています。

主要情報

66.8%

収益成長率

66.4%

EPS成長率

Medical Equipment 収益成長	35.3%
収益成長率	24.0%
将来の株主資本利益率	18.3%
アナリストカバレッジ	Low
最終更新日	21 Nov 2024

今後の成長に関する最新情報

Recent updates

We Think Ray (KOSDAQ:228670) Has A Fair Chunk Of Debt

Nov 13

Ray Co., Ltd. (KOSDAQ:228670) Not Doing Enough For Some Investors As Its Shares Slump 32%

Aug 05

What Type Of Shareholders Make Up Ray Co., Ltd.'s (KOSDAQ:228670) Share Registry?

Feb 21

With A Return On Equity Of 13%, Has Ray Co., Ltd.'s (KOSDAQ:228670) Management Done Well?

Feb 02

We Wouldn't Rely On Ray's (KOSDAQ:228670) Statutory Earnings As A Guide

Jan 14

If You Had Bought Ray (KOSDAQ:228670) Shares A Year Ago You'd Have Earned 11% Returns

Dec 27

Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly

Dec 08

Has Ray (KOSDAQ:228670) Got What It Takes To Become A Multi-Bagger?

Nov 19

業績と収益の成長予測

KOSDAQ:A228670 - アナリストの将来予測と過去の財務データ ( )KRW Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	208,868	25,549	7,228	38,500	3
12/31/2025	167,891	20,232	-6,682	29,000	3
12/31/2024	92,100	13,708	2,000	5,000	1
6/30/2024	128,613	-22,552	-39,529	-36,932	N/A
3/31/2024	143,226	-4,452	-37,230	-34,649	N/A
12/31/2023	145,882	-2,146	-25,443	-22,791	N/A
9/30/2023	145,143	7,518	-23,985	-20,132	N/A
6/30/2023	139,591	6,462	-46,909	-19,720	N/A
3/31/2023	131,396	5,346	-41,773	-10,358	N/A
12/31/2022	128,998	7,957	-40,940	-8,231	N/A
9/30/2022	108,356	-5,628	-54,083	-4,501	N/A
6/30/2022	100,533	-2,984	-19,860	8,764	N/A
3/31/2022	93,026	1,241	-13,752	10,660	N/A
12/31/2021	90,336	-13	-12,233	11,172	N/A
9/30/2021	84,681	12,727	9,300	15,001	N/A
6/30/2021	73,676	9,988	8,771	15,267	N/A
3/31/2021	57,803	4,645	921	8,407	N/A
12/31/2020	55,205	7,904	-4,416	2,903	N/A
9/30/2020	57,260	7,979	-5,194	2,262	N/A
6/30/2020	61,781	8,891	-5,777	-874	N/A
3/31/2020	71,986	12,340	125	3,760	N/A
12/31/2019	73,109	11,555	2,546	6,040	N/A
9/30/2019	69,512	10,843	1,694	4,973	N/A
3/31/2019	57,594	7,019	984	3,371	N/A
12/31/2018	51,534	5,251	2,011	4,298	N/A
12/31/2017	32,929	1,154	N/A	1,101	N/A
12/31/2016	26,499	1,713	N/A	582	N/A
12/31/2015	20,528	207	N/A	-1,370	N/A

アナリストによる今後の成長予測

収入対貯蓄率: A228670は今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.7% ) よりも高い成長率であると考えられます。

収益対市場: A228670今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: A228670今後 3 年以内に収益を上げることが予想されます。

収益対市場: A228670の収益 ( 24% ) KR市場 ( 9.4% ) よりも速いペースで成長すると予測されています。

高い収益成長: A228670の収益 ( 24% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: A228670の自己資本利益率は、3年後には低くなると予測されています ( 18.3 %)。

Ray 将来の成長

Future 基準チェック /56

主要情報

今後の成長に関する最新情報

Price target decreased by 7.8% to ₩30,800

Price target decreased by 7.9% to ₩43,000

Consensus EPS estimates fall by 37%

Price target decreased to ₩29,900

Price target decreased to ₩38,767

Price target decreased to ₩38,767

Recent updates

We Think Ray (KOSDAQ:228670) Has A Fair Chunk Of Debt

Ray Co., Ltd. (KOSDAQ:228670) Not Doing Enough For Some Investors As Its Shares Slump 32%

New minor risk - Share price stability

Ray (KOSDAQ:228670) Has A Somewhat Strained Balance Sheet

New minor risk - Shareholder dilution

Market Still Lacking Some Conviction On Ray Co., Ltd. (KOSDAQ:228670)

New major risk - Financial position

Price target decreased by 7.8% to ₩30,800

New minor risk - Shareholder dilution

Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.

Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.

Full year 2023 earnings released: ₩140 loss per share (vs ₩541 profit in FY 2022)

The Returns On Capital At Ray (KOSDAQ:228670) Don't Inspire Confidence

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: ₩231 (vs ₩172 in 3Q 2022)

Now 22% undervalued after recent price drop

Price target decreased by 7.9% to ₩43,000

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 32%

Consensus EPS estimates fall by 37%

Investor sentiment improves as stock rises 18%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Now 21% undervalued

Price target decreased to ₩29,900

Price target decreased to ₩38,767

Full year 2021 earnings: EPS and revenues miss analyst expectations

Price target decreased to ₩38,767

Third quarter 2021 earnings released: EPS ₩381 (vs ₩181 in 3Q 2020)

Ray Co., Ltd. announced that it has received KRW 31.5 billion in funding

Ray Co., Ltd. announced that it expects to receive KRW 31.5 billion in funding

Full year 2020 earnings released: EPS ₩1,188 (vs ₩1,915 in FY 2019)

Is Ray (KOSDAQ:228670) Using Too Much Debt?

Ray Co., Ltd., Annual General Meeting, Mar 31, 2021

Investor sentiment deteriorated over the past week

What Type Of Shareholders Make Up Ray Co., Ltd.'s (KOSDAQ:228670) Share Registry?

Investor sentiment improved over the past week

New 90-day high: ₩62,500

With A Return On Equity Of 13%, Has Ray Co., Ltd.'s (KOSDAQ:228670) Management Done Well?

We Wouldn't Rely On Ray's (KOSDAQ:228670) Statutory Earnings As A Guide

New 90-day high: ₩56,300

If You Had Bought Ray (KOSDAQ:228670) Shares A Year Ago You'd Have Earned 11% Returns

New 90-day high: ₩47,300

Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly

Has Ray (KOSDAQ:228670) Got What It Takes To Become A Multi-Bagger?

Market bids up stock over the past week

New 90-day low: ₩40,200

New 90-day low - ₩41,100

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘